18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.pdf

18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.pdf

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis

18F-FDG PET for Evaluation of Bone Marrow Infiltration in Staging of Lymphoma: A Meta-Analysis Emilios E. Pakos, MD1; Andreas D. Fotopoulos, MD2; and John P.A. Ioannidis, MD1,3,4 1Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; 2Department of Nuclear Medicine, University Hospital of Ioannina, School of Medicine, Ioannina, Greece; 3Biomedical Research Institute, Foundation for Research and Technology–Hellas, Ioannina, Greece; and 4Department of Medicine, Institute for Clinical Research and Health Policy Studies, Tufts–New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts The ability of PET with 18F-FDG to evaluate bone marrow infil- tration in patients with lymphoma has been a matter of exten- sive investigation with controversial results. Therefore, we aimed to evaluate systematically, with a meta-analysis, the di- agnostic performance of 18F-FDG PET in this setting. Methods: Relevant studies were identified with MEDLINE and EMBASE searches (last update, August 2004). Data on the diagnostic performance of 18F-FDG PET were combined quantitatively across eligible studies. We estimated weighted summary sen- sitivities and specificities, summary receiver-operating-charac- teristic (SROC) curves, and weighted summary likelihood ratios. We also conducted separate analyses according to various subgroups. Bone marrow biopsy (BMB) was used as the refer- ence standard. Results: Thirteen eligible nonoverlapping stud- ies, which enrolled a total of 587 patients, were included in the meta-analysis. The independent random-effects weighted esti- mates of sensitivity and specificity against BMB were 51% (95% confidence interval [CI], 38%–64%) and 91% (95% CI, 85%–95%), respectively. Results were consistent in the SROC curve: a sensitivity of 51% corresponds to a specificity of 92%, whereas a specificity of 91% corresponds to a sensitivity of 55%. The weigh

文档评论(0)

l215322 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档